Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Abbott Laboratories (ABT) has a market cap of $178.49B with year-over-year revenue growth of +5.7%. Net margin stands at 14.7%. The stock trades at a P/E ratio of 27.4.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ABT posted revenue growth of +5.7% and trades at a P/E of 27.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.